Vicarious Surgical Inc. (RBOT)
NYSE: RBOT · Real-Time Price · USD
8.05
-0.01 (-0.12%)
Nov 5, 2024, 3:45 PM EST - Market open

Vicarious Surgical Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Selling, General & Admin
28.3233.0936.1816.163.192.3
Research & Development
41.6746.8543.922.069.87.48
Operating Expenses
69.9979.9480.0838.2212.999.78
Operating Income
-69.99-79.94-80.08-38.22-12.99-9.78
Interest Expense
-0.02-0.03-0.2-0.09-0-0
Interest & Investment Income
3.814.431.440.020.110.47
Other Non Operating Income (Expenses)
5.915.19843.09--
EBT Excluding Unusual Items
-60.29-70.345.16-35.21-12.88-9.31
Merger & Restructuring Charges
-0.73-0.73----
Pretax Income
-61.02-71.075.16-35.21-12.88-9.31
Net Income
-61.02-71.075.16-35.21-12.88-9.31
Net Income to Common
-61.02-71.075.16-35.21-12.88-9.31
Shares Outstanding (Basic)
654330
Shares Outstanding (Diluted)
654330
Shares Change (YoY)
36.92%14.49%31.89%22.80%1501.50%-
EPS (Basic)
-10.72-14.601.27-10.92-4.91-56.83
EPS (Diluted)
-10.81-14.701.20-10.92-4.91-56.83
Free Cash Flow
-55.3-63.98-66.56-34.59-12.16-8.96
Free Cash Flow Per Share
-9.72-13.14-15.66-10.73-4.63-54.66
EBITDA
-67.96-78.08-78.97-37.91-12.83-9.68
D&A For EBITDA
2.031.851.110.320.160.1
EBIT
-69.99-79.94-80.08-38.22-12.99-9.78
Source: S&P Capital IQ. Standard template. Financial Sources.